NCT07277413 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07277413
Title	A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	IDEAYA Biosciences
Indications	esophagus adenocarcinoma malignant pleural mesothelioma gastroesophageal junction adenocarcinoma urethra transitional cell carcinoma ureter transitional cell carcinoma gastric adenocarcinoma lung adenocarcinoma bladder urothelial carcinoma lung squamous cell carcinoma esophagus squamous cell carcinoma lung non-small cell carcinoma adenosquamous lung carcinoma Advanced Solid Tumor peritoneal mesothelioma renal pelvis transitional cell carcinoma
Therapies	IDE892 IDE397 + IDE892
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
NEXT Oncology Houston	RECRUITING	Houston	Texas	77054	United States	Details
NEXT Oncology Dallas	RECRUITING	Irving	Texas	75039	United States	Details
NEXT Oncology Virginia	RECRUITING	Fairfax	Virginia	22031	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07277413Clinical Trial Detail